FACS analysis of Annexin V-PI staining at 72 h post-treatment demonstrated a favorable cytotoxicity profile of the combinatorial treatment in PBMCs, as compared to the MM cell line KMS28-BM (Figure 4a). Here, ANXA5 is linked to Miyoshi myopathy.